T. Rowe Price Associates’s Outset Medical OM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Buy |
+11,427
| New | +$220K | ﹤0.01% | 2669 |
|
|
2025
Q1 | – | Sell |
-2,620
| Closed | -$44K | – | 3060 |
|
|
2024
Q4 | $44K | Sell |
2,620
-2,020
| -44% | -$33.9K | ﹤0.01% | 2948 |
|
|
2024
Q3 | $48K | Hold |
4,640
| – | – | ﹤0.01% | 2933 |
|
|
2024
Q2 | $268K | Sell |
4,640
-869
| -16% | -$50.2K | ﹤0.01% | 2466 |
|
|
2024
Q1 | $184K | Buy |
5,509
+2,366
| +75% | +$79K | ﹤0.01% | 2645 |
|
|
2023
Q4 | $256K | Buy |
3,143
+1,154
| +58% | +$94K | ﹤0.01% | 2441 |
|
|
2023
Q3 | $325K | Buy |
1,989
+65
| +3% | +$10.6K | ﹤0.01% | 2296 |
|
|
2023
Q2 | $632K | Buy |
1,924
+574
| +43% | +$189K | ﹤0.01% | 2022 |
|
|
2023
Q1 | $373K | Sell |
1,350
-1,072
| -44% | -$296K | ﹤0.01% | 2236 |
|
|
2022
Q4 | $938K | Sell |
2,422
-66
| -3% | -$25.6K | ﹤0.01% | 1804 |
|
|
2022
Q3 | $595K | Sell |
2,488
-187,449
| -99% | -$44.8M | ﹤0.01% | 2036 |
|
|
2022
Q2 | $42.3M | Buy |
189,937
+28,909
| +18% | +$6.44M | 0.01% | 934 |
|
|
2022
Q1 | $110M | Buy |
161,028
+55,517
| +53% | +$37.8M | 0.01% | 700 |
|
|
2021
Q4 | $72.9M | Buy |
105,511
+2,116
| +2% | +$1.46M | 0.01% | 866 |
|
|
2021
Q3 | $76.7M | Sell |
103,395
-147,281
| -59% | -$109M | 0.01% | 860 |
|
|
2021
Q2 | $188M | Sell |
250,676
-62,614
| -20% | -$46.9M | 0.02% | 582 |
|
|
2021
Q1 | $256M | Buy |
313,290
+2,737
| +0.9% | +$2.23M | 0.03% | 484 |
|
|
2020
Q4 | $254M | Buy |
310,553
+5,261
| +2% | +$4.31M | 0.03% | 465 |
|
|
2020
Q3 | $220M | Buy |
+305,292
| New | +$220M | 0.03% | 463 |
|